BURLINGTON, Mass., Feb. 24 12, 2022 (GLOBE NEWSWIRE) — Keystone Dental Holdings, Inc. (“Keystone Dental”), a global commercial-stage medical technology company with a comprehensive portfolio of tooth replacement solutions including implants, prosthetic solutions, biomaterial solutions and digital dentistry capabilities, announced that effective March 1, 2022, Ofer Zigman will join the company as Vice President of R&D and Kishore Pranjivan will join the company as Country Director Canada.
Melker Nilsson, CEO of Keystone Dental, said, “We are delighted to welcome Kishore and Ofer to the Keystone leadership team. Geographic expansion and continued innovation are key elements of our growth strategy as we emerge into the market as a global provider of tooth replacement solutions. I am very pleased to add two distinguished individuals in their respective roles to lead these facets of our business. »
Mr. Zigman, who assumes responsibility for Keystone’s Israeli development team, brings more than 15 years of management-level experience in the medical device industry, including seven years leading R&D teams. in the dental implant industry. In this new role at Keystone Dental, Mr. Zigman will primarily focus on R&D and product management. He will also oversee new product development and support the acceleration of Keystone Dental’s development pipeline. Most recently, Mr. Zigman served as Vice President of R&D at Hospitech Respiration, formulating the company’s innovation roadmap and execution. Previously, he was Vice President of Product and R&D at AlphaBio Tec (ABT), where he led dental implant developments and go-to-market strategy. Prior to AlphaBio Tec, he was Vice President of R&D at Xenolith Medical, where he oversaw product development from concept to commercialization.
Mr. Pranjivan is responsible for establishing and growing Keystone Dental’s direct sales organization in Canada. Mr. Pranjivan has more than 30 years of experience in the dental market, including more than 20 years in senior management and director positions with Nobel Biocare. During his tenure at Nobel Biocare, Mr. Pranjivan held various subsidiary positions, such as Regional Manager in Australia and Asia, Country Manager in Canada, and Regional Manager in the UK and Ireland.
Most recently, Mr. Pranjivan held the position of Director of Special Markets and Institutions at Henry Schein Canada. In this role, his primary focus was the development and support of group practices and DSOs in Canada.
About Keystone Dental Holdings, Inc.
Keystone Dental is a commercial-stage global medical technology company focused on providing end-to-end solutions for dental practitioners and tooth replacement procedures. Headquartered in Burlington, Massachusetts, with a distribution facility in Irvine, California, and research and development and manufacturing sites in Caesarea, Israel, and Melbourne, Australia, Keystone Dental markets its products globally. whole. The company’s comprehensive portfolio of tooth replacement solutions includes implants, prosthetic solutions, biomaterials solutions and digital dentistry capabilities. It includes proprietary offerings such as Osteon, Nexus iOS, Genesis – The Biomimetic Implant System™, the TILOBEMAXX™, PrimaConnex® and Prima Plus™ Implant Systems, the DynaMatrix® extracellular membrane, and the Dyna Blast® and DynaGraft D® bone graft substitutes. Keystone acquired Implant Solutions Pty Ltd (“Osteon”) in 2021, adding a comprehensive portfolio of implant prosthetic solutions and digital workflow capabilities. For more information, visit www.keystonedental.com.